Institutt for farmasi: Recent submissions
Now showing items 481-500 of 656
-
Statement complementing the EFSA opinion on application EFSA GMO UK 2007 41 (cotton MON 88913 for food and feed uses, import and processing) taking into consideration updated bioinformatic analyses
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Scientific Opinion on application (EFSA-GMO-NL-2010-77) for the placing on the market of herbicide-tolerant genetically modified cotton GHB614 × LLCotton25 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Scientific Opinion on the annual post-market environmental monitoring (PMEM) report from Monsanto Europe S.A. on the cultivation of genetically modified maize MON 810 in 2012
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in Flpln-3T3 cells stably expressing either the Pax6 or the Pax6(5a) Isoform
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-07-14) -
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Detecting rare gene transfer events in bacterial populations
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Humoral and cellular immune responses in mice after airway administration of Bacillus thuringiensis Cry1Ab and MON810 cry1Ab-transgenic maize
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)Genetically modified (GM) crops may bring new proteins with immunogenic and allergenic properties into the food and feed chains. The most commonly grown GM maize, MON810, expresses a modified version of the insecticidal Cry1Ab protein originating in the soil bacterium Bacillus thuringiensis(Bt). Immune reactions following inhalation of pollen and debris from such plants have been scarcely studied. ... -
Phospholipid Vesicle-Based Permeation Assay and EpiSkin in Assessment of Drug Therapies Destined for Skin Administration
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014) -
Elastic liposomes-in-vehicle formulations destined for skin therapy: the synergy between type of liposomes and vehicle
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-07-14) -
Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-03-19)Penetration potential of vesicles destined for trans(dermal) administration remains to be of great interests both in respect to drug therapy and cosmetic treatment. This study investigated the applicability of the phospholipid vesicle-based permeation assay (PVPA) as a novel in vitro skin barrier model for screening purposes in preformulation studies. Various classes of liposomes containing hydrophilic ... -
Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)The choice of drug therapy in pregnant patients suffering from vaginal infections is limited by the safety profile of the drug. Assuring the efficient topical therapy to avoid systemic absorption is considered the best therapy option. Chitosan-coated liposomes have been developed and optimized to assure localized therapy of clotrimazole. Chitosan was selected as mucoadhesive polymer both to prolong ... -
Improved Permeability of Acyclovir: Optimization of Mucoadhesive Liposomes Using the Phospholipid Vesicle-Based Permeation Assay
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-01-06) -
Bioadhesive Mini-Tablets for Vaginal Drug Delivery
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-08-27) -
Chitosan in Mucoadhesive Drug Delivery: Focus on Local Vaginal Therapy
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-01-07)Mucoadhesive drug therapy destined for localized drug treatment is gaining increasing importance in today’s drug development. Chitosan, due to its known biodegradability, bioadhesiveness and excellent safety profile offers means to improve mucosal drug therapy. We have used chitosan as mucoadhesive polymer to develop liposomes able to ensure prolonged residence time at vaginal site. Two types of ... -
Antibiotikaresistens - kunnskapshull, utfordringer og aktuelle tiltak. Rapport fra tverrsektoriell ekspertgruppe
(Research report; Forskningsrapport, 2014)